Multiple Assemblies exist for SMTL entry 5lli
pVHL:EloB:EloC in complex with VH298; X-RAY DIFFRACTION 2.40 Å

	SMTL ID 5lli.1 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-cyanocyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 5lli.2 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-cyanocyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 5lli.3 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-cyanocyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 5lli.4 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-cyanocyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer